ArticleBioelectronic medicine2024

Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study.

Daniel Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.